Independent opinions of independent directors on hiring audit institutions in 2022
In accordance with the Listing Rules of Shenzhen Stock Exchange, the governance standards of listed companies, the guidance on the establishment of independent director system in listed companies, the articles of association, the independent director system and other relevant regulations and systems, as independent directors of Berry Genomics Co.Ltd(000710) (hereinafter referred to as “the company”), we express independent opinions on the company’s engagement of an audit institution in 2022 as follows:
1. After verification, Shanghui Certified Public Accountants (special general partnership) has the qualification to engage in Securities and futures related businesses. In the process of undertaking various audits of the company in 2021, it has better fulfilled the responsibilities and obligations of both parties. The audit report issued can objectively and truly reflect the company’s financial status and operating results, and can meet the requirements of the company’s future financial audit and internal control audit.
2. In order to ensure the continuity of the company’s audit work, we agree to continue to hire Shanghui Certified Public Accountants (special general partnership) as the company’s audit institution in 2022 to be responsible for the company’s financial audit and internal control audit in 2022 for one year, and submit to the general meeting of shareholders to authorize the company’s management to follow the market fair and reasonable pricing principle and refer to the cost standard in 2021, Negotiate with Shanghai accounting firm (special general partnership) to determine the remuneration for audit work in 2022.
3. We agree to the proposal of employing Shanghui accounting firm (special general partnership) as the audit institution of the company in 2022 reviewed and approved by the board of directors, and agree to submit the proposal to the 2021 annual general meeting of shareholders for deliberation. Independent directors: Wang Xiuping, Li Guangchao, Wang Sijia April 14, 2022
